US 8399219
Protease activatable interferon alpha proprotein
granted A61KA61K38/00A61K47/64
Quick answer
US patent 8399219 (Protease activatable interferon alpha proprotein) held by CytomX Therapeutics, Inc. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K47/64, A61K47/65, A61P